Genelized anxiety disorder. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Conditions
Interventions
Intervention 1: relaxation therapy, 12 weekly session,. Intervention 2: meta cognitive therapy, 12 weekly session,. Intervention 3: Buspirone, 10 mg oral tablet, three times a day for three months. I
Behavior
Treatment - Drugs
relaxation therapy, 12 weekly session,
meta cognitive therapy, 12 weekly session,
Buspirone, 10 mg oral tablet, three times a day for three months.
venlafaxine, 75 mg oral tablet, three times a day for three months.
Sponsors
Clinical Psychiatric Research Center- tabriz university of medical science
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion citeria: Age, at least 18 years and maximum 50 years; generalized anxiety disorder diagnoses based on structured clinical interview based on DSM-VI-TR and confirm the diagnosis according to a psychiatrist or clinical psychologist; having a minimum qualification cycle and ability to read and write and speak fluently. Exclusion criteria: psychotic disorder; obsessive - compulsive disorder; drug dependence; epilepsy syndrome and using any recreational drug and mental health three months before the first treatment session.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Before treatment, after treatment, 3 month after treatment. Method of measurement: Beck anxiety inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Worry. Timepoint: Before treatment, after treatment, 3 month after treatment. Method of measurement: Pennsylvania State Worry Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Gholizadeh
Welfare organization
Outcome results
None listed